Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet and coagulation functions during triphasic oestrogen-progestogen treatment.

V Bruni, D Rosati, S Bucciantini

    Contraception
    |January 1, 1986
    PubMed
    Summary

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Assessing the Feasibility and Acceptability of VA Whole Health Coaching Among Veterans With Complex Health Care Needs-A Pilot Study.

    American journal of lifestyle medicine·2026
    Same author

    Evaluation of the concordance of asthma remission definitions according to international guidelines in a cohort of patients treated with monoclonal antibodies for severe asthma.

    Frontiers in pharmacology·2026
    Same author

    Metabolomic profiling of saliva from cystic fibrosis patients.

    Scientific reports·2025
    Same author

    Understanding the role of cerebellum in early Parkinson's disease: a structural and functional MRI study.

    NPJ Parkinson's disease·2024
    Same author

    Very low serum IGF-1 levels are associated with vertebral fractures in adult males with beta-thalassemia major.

    Journal of endocrinological investigation·2024
    Same author

    Temporal trends in the clinical presentation of Graves' orbitopathy: a single-center retrospective study.

    Journal of endocrinological investigation·2024

    This study found that triphasic oral contraceptives do not alter platelet function or significantly impact blood clotting markers over six months. Coagulation activation is minimal and counteracted by natural inhibitors.

    Area of Science:

    • Pharmacology
    • Hematology
    • Thrombosis Research

    Background:

    • Hormonal contraceptives can influence the hemostatic system.
    • Understanding the thrombotic risk associated with oral contraceptives is crucial.

    Purpose of the Study:

    • To longitudinally evaluate the hemostatic system's response to a triphasic oestrogen-progestogen combination.
    • To assess changes in platelet function and coagulation markers over 6 months.

    Main Methods:

    • Longitudinal study design.
    • Measurement of circulating platelet aggregates and megathrombocytes.
    • Assay of Fibrinopeptide A (FPA) and Antithrombin III (AT III) activity.

    Main Results:

    • No significant changes in platelet aggregation or megathrombocytes were observed.
    Keywords:
    BiologyBlood Coagulation Effects--changesContraceptionContraceptive AgentsContraceptive Agents, EstrogenContraceptive Agents, FemaleContraceptive Agents, ProgestinContraceptive Methods--side effectsData AnalysisDiseasesEndocrine SystemEthinyl EstradiolExaminations And DiagnosesFamily PlanningHematological Effects--changesHemic SystemHormonesLaboratory Examinations And DiagnosesLaboratory ProceduresLevonorgestrelOral Contraceptives--side effectsPhysiologyPlatelet Aggregation--changesReproductive Control AgentsResearch Methodology

    Related Experiment Videos

  • A transient, slight increase in Fibrinopeptide A (FPA) was noted at 1 month, but not sustained.
  • Antithrombin III (AT III) activity showed a minor increase at 3 months, returning to baseline by 6 months.

    • Conclusions:

    • Triphasic oral contraceptives do not appear to impair platelet function.
    • A low-degree activation of coagulation occurs, effectively counterbalanced by enhanced activity of endogenous anticoagulants.